Physician profile
Robert C Finley
NPI 1891845145
$731.66
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $31.29 · 2021: $361 · 2022: $192 · 2023: $20.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $103.97 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $99.55 | 2019-2021 | |
| Medtronic, INC. | $76.04 | 2022-2023 | Corevalve Evolut R |
| Lundbeck LLC | $59.43 | 2021 | |
| Ucb, INC. | $50.54 | 2021 | |
| Abbvie INC. | $49.94 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $43.77 | 2021-2022 | |
| Amneal Pharmaceuticals LLC | $38.47 | 2021-2022 | |
| Tanabe Pharma America, INC. | $31.45 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $28.59 | 2019 | |
| Allergan, INC. | $28.27 | 2019-2020 | |
| Biogen, INC. | $24.55 | 2019-2021 | |
| Harmony Biosciences LLC | $20.63 | 2021 | |
| Ge Healthcare | $19.44 | 2020 | |
| Genzyme Corporation | $17.10 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $14.52 | 2021 | |
| Catalyst Pharmaceuticals, INC. | $13.30 | 2021 | |
| Grifols USA, LLC | $12.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Finley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.